Cancer care

Recent antibiotic reduces cancer survival after immune checkpoint inhibitors by 12%, study results show

Results from a Canadian cohort study suggest that antibiotic therapy may reduce the effectiveness of immune checkpoint inhibitor therapy.…

Community pharmacies to start directly referring patients for cancer screening from January 2023

Exclusive: The first phase of the pilot is planned to begin this month, with further pharmacies to start referring patients in March/April 2023.…

Research, CPD and Learning: 2022 in review

Celebrating the highlights from 2022 and a look ahead to 2023.…

Cancer vaccine combined with monoclonal antibody cuts risk of death or recurrence of melanoma by almost 50%, show phase II trial data

Experts say the data are exciting, but warn larger trials are needed in other cancer types.…

Monoclonal antibodies for the treatment of multiple myeloma

An overview of the development and use of monoclonal antibodies in the treatment of patients with multiple myeloma.…

Don’t dismiss fears over switching generics, take it from two cancer ‘thrivers’

Ruth Edwards and Avril Chester share their experience of the impact medicines shortages can have on people who rely on long-term medicines after cancer treatment.…

Compassionate medicine schemes help patients with cancer live better and for longer — why are they not more widely used?

Use of unlicensed or off-label medicines for patients with cancer can extend survival or improve quality of life, but access remains patchy.…

The role of circulating tumour DNA in guiding cancer treatment and future applications

An overview of current and future applications of circulating tumour DNA in common solid tumours and the implications on treatment.…

Immune-related cancer toxicities: what pharmacists need to know

In this episode of The PJ Pod, we explore the side effects of cancer immunotherapy and consider what pharmacists can do to support patients throughout the course of their treatment.…

Supported content

Renal cancer: management

An overview of the most common forms of renal cancer, treatment options and the role of pharmacists in its management.…

Supported content